Oncologic Emergencies Part 2 Flashcards

1
Q

Tumor Lysis Syndrome Risk Factors

A
	Tumor with high proliferative rate
	Tumor sensitive to cytotoxic therapy
	Large tumor masses
	Leukocytosis
	High LDH
	Pre-existing renal insufficiency
	Hematologic malignancies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LDH + Tumor Lysis

A

Indirect measurement of patient’s tumor burden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tumors sensitive to cytotoxic therapy –>

A

Tumors that are more sensitive will have more dying and releasing of components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Highest Risk of TLS

A

Burkitt’s lymphoma
Lymphoblastic lymphoma
ALL
AML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Moderate Risk of TLS

A

Multiple myeloma
Breast cancer
Small cell lung
Germ cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Tumor Lysis Syndrome

A

 Rapid lysis of tumor cells leads to release of intracellular content which leads to exceeding ability for normal compensatory mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Findings with TLS

A

Hyperuricemia
Hyperkalemia
Hyperphosphatemia
Hypocalcemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Consequence of TLS

A

Renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hyperkalemia leads to

A

Cardiac and neuromuscular complications (cramps)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyperphosphotemia leads to

A

GI symptoms, lethargy and seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hypocalcemia

A

Leads to cardiac arrhythmia, hypotension, tetany

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hydration + TLS

A
  • Initiate 24-48 hours prior to therapy
  • Continue until 48-72 hours after therapy
  • Diuretics should be considered to have equal fluid intake and output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alkalinize Urine + TLS

A

• Sodium bicarbonate or acetazolamide (inhibiters carbonic anhydrase → increases pH → increase solubility of uric acid)
GENERALLY NOT RECOMMENDED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Allopurinol MOA and Dose

A

Inhibits xanthine oxidase so it inhibits the formation of uric acid
Dose: LD of 600 mg and then 300 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rasburicase MOA and Use

A
  • Urate acid is converted to Allatoin via urate oxidase and is 5-10X more soluble than urate acid so it will get cleared quicker
  • This prevents hyperuricemia and TLS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Rasburicase Dose, CI, AE

A

Dose: 6 mg once daily
CI: G6PD deficiency
AE: urticaria, fever, N/V

17
Q

High Risk Treatment of TLS

A

Hydration and rasburicase

18
Q

Intermediate Risk Treatment of TLS

A

Hydration, allopurinol

19
Q

Low Risk Treatment of TLS

A

Clinical judgement and monitoring

20
Q

Close monitoring and imagining for TLS

A
  • CBC
  • Electrolytes
  • Renal function
  • Urine analysis to monitor pH (not necessary)
  • Fluid intake and output (make sure good flow to kidneys, so all the electrolytes and enzymes are removed quickly
21
Q

Superior Vena Cave Syndrome Leads to

A
	Increased venous pressure
	Airway obstruction
	Cerebral edema
	Decreased cardiac filling
	Decreased cardiac output
22
Q

Signs and SYmptoms of SVC

A
	Dyspnea, tachypnea
	Cough
	Venous distension
	Facial or arm edema
	Chest pain (upper part- head should and upper chest)
	Dysphagia
	Sensation of fullness in head
	Cyanosis
23
Q

Causes of SVC

A

 Lung cancers – SCLC
 Lymphomas – NHL and HD
 Head and neck cancers

24
Q

Diagnosis of SVC

A

 Chest X-ray
 CT scan: neck and chest
 Venography: if thrombus expected
 Biopsy of mass (confirm that it is cancer)

25
Q

Treatment of SVC

A

Goal: relieve symptoms and prevent complications

Chemotherapy or radiation (most common first line and them chemo)

26
Q

Supportive Measures for SVC

A
	Bed rest 
	Oxygen
	Corticosteroid
	Diuretics
	Low salt diet
27
Q

Spinal Cord Compression Presentation

A

 Hematologic that have metastasized to the bone to lead to compression of the spinal cord

28
Q

Signs and Symptoms of PCC

A
	Pain >90% of patients
	Neurologic symptoms
•	Motor: weakness, spasticity
•	Sensory: numbness, ataxia
•	Autonomic dysfunction (loss of control of bowel movements)
•	Paraplegia
29
Q

Diagnosis of PCC

A

X-ray of spine

MRI/CT of spine

30
Q

Treatment of PCC

A

Dexamethasone to reduce edema

Radiation (treatment of choice)